April 2009
Volume 50, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2009
Sensitivity to TGF-Beta by T Cells Is Not Required for the Activation of Splenic CD8+ Regulatory T Cells by the Intracameral Injection of Antigen but Is Required for the Suppression of a Delayed Hypersensitivity Reaction by Anterior Chamber-Induced Splenic CD8+ T Cells
Author Affiliations & Notes
  • R. E. Cone
    Immunology, Univ of Connecticut Health Ctr, Farmington, Connecticut
  • S. Chattopadhyay
    Immunology, Univ of Connecticut Health Ctr, Farmington, Connecticut
  • R. Sharafieh
    Immunology, Univ of Connecticut Health Ctr, Farmington, Connecticut
  • Y. Lemire
    Immunology, Univ of Connecticut Health Ctr, Farmington, Connecticut
  • J. O'Rourke
    Immunology, Univ of Connecticut Health Ctr, Farmington, Connecticut
  • R. A. Flavell
    Section of Immunobiology, Yale University, New Haven, Connecticut
  • R. B. Clark
    Immunology, Univ of Connecticut Health Ctr, Farmington, Connecticut
  • Footnotes
    Commercial Relationships  R.E. Cone, None; S. Chattopadhyay, None; R. Sharafieh, None; Y. Lemire, None; J. O'Rourke, None; R.A. Flavell, None; R.B. Clark, None.
  • Footnotes
    Support  NIH grants EY017289,EY017537, AI072 533(RBC) and the Connecticut Lions Eye Research Foundation
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 3034. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      R. E. Cone, S. Chattopadhyay, R. Sharafieh, Y. Lemire, J. O'Rourke, R. A. Flavell, R. B. Clark; Sensitivity to TGF-Beta by T Cells Is Not Required for the Activation of Splenic CD8+ Regulatory T Cells by the Intracameral Injection of Antigen but Is Required for the Suppression of a Delayed Hypersensitivity Reaction by Anterior Chamber-Induced Splenic CD8+ T Cells. Invest. Ophthalmol. Vis. Sci. 2009;50(13):3034.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : The intracameral injection of antigen induces the production of splenic CD8+ regulatory T cells (AC-SPL cells) that suppress effector T cells that induce a delayed type hypersensitivity (DTH) reaction. Because CD8+ regulatory T cells are also induced in vitro by TGF-β or F4/80+ cells exposed to TGF-β and antigen in vitro, we investigated (i) whether sensitivity to TGF-β is required to produce CD8+ AC-SPL cellsafter the intracameral injection of antigen and (ii) for the suppression of a DTH reaction by CD8+ AC-SPL cells.

Methods: : dnTGFβRII or Cbl-b -/- mice whose T cells are resistant to TGF-β received an intracameral injection of TNP-BSA and then were immunized with TNP-BSA. The ability of total AC-SPL cells and CD8+ AC-SPL cells recovered from these mice to suppress DTH was measured by the injection of these cells into the footpads of TNP-BSA-immunized wildtype recipients after the footpads were challenged with picryl chloride (PCl). TNP-BSA-immunized dnTGFβRII, Cbl-b -/- or wildtype mice were the recipients of wildtype CD8+ AC-SPL cells when challenged with PCl. Immunized wildtype mice received wildtype AC-SPL cells and antibodies to TGF-β when the footpads were challenged with PCl.

Results: : DnTGFβRII-immunized and Cbl-b-/- mice produced splenic CD8+ regulatory cells after the intracameral injection of antigen and immunization. The suppression of a DTH reaction by CD8+ AC-SPL cells in wildtype mice was blocked by the local inclusion of antibodies to TGF-β 1-3. Moreover, the DTH reaction in immunized dnTGFβRII and Cbl-b -/- mice was not suppressed by wildtype CD8+ AC-SPL cells.

Conclusions: : these observations suggest that T cell sensitivity to TGF-β is not an obligate requirement for the in vivo induction of CD8+ AC-SPL T cells but the suppression of a DTH reaction by CD8+ AC-SPL cells is dependent on TGF-β.

Keywords: immune tolerance/privilege • immunomodulation/immunoregulation • ACAID 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×